Income Tax Expense (Benefit) of HTG MOLECULAR DIAGNOSTICS, INC from 31 Dec 2015 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2015 to 31 Mar 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Income Tax Expense (Benefit) for the quarter ending 31 Mar 2023 was $2,218, a 475% increase year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC Income Tax Expense (Benefit) for the twelve months ending 31 Mar 2023 was $12,669, a 38% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Income Tax Expense (Benefit) for 2022 was $10,837, a 52% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Income Tax Expense (Benefit) for 2021 was $22,475, a 56% increase from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Income Tax Expense (Benefit) for 2020 was $14,415, a 327% increase from 2019.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $12,669 $2,218 +$1,832 +475% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $10,837 $3,999 +$2,167 +118% 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
Q3 2022 $8,670 $1,572 -$362 -19% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $9,032 $4,880 -$11,380 -70% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $20,412 $386 -$2,063 -84% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $22,475 $1,832 -$35 -1.9% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $22,510 $1,934 +$353 +22% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $22,157 $16,260 +$10,469 +181% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $11,688 $2,449 -$2,727 -53% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $14,415 $1,867 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $1,581 +$5,259 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $5,791 -$1,057 -15% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $5,176 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 $3,678 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $6,848 +$3,303 +93% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2
Q2 2018 $3,545 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q3 2017 $743 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q1 2017 $280 -$3,119 -92% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q2 2016 $860 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $3,399 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

HTG MOLECULAR DIAGNOSTICS, INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $10,837 -$11,638 -52% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2021 $22,475 +$8,060 +56% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $14,415 +$11,036 +327% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $3,379 -$147 -4.2% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $3,526 +$605 +21% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020 2019 FY
2017 $2,921 -$7,197 -71% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $10,118 -$71 -0.7% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018 2017 FY
2015 $10,189 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.